MORGAN STANLEY

Position in FATE — Fate Therapeutics Inc

CIK 895421 NEW YORK, NY

Back to FATE Full portfolio

Position in FATE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$921,295

+$22,691 QoQ

Shares Held

767,748

-16.3% QoQ

Ownership

0.659%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 96.16618994774328.ToString("F0")% Shared 0.ToString("F0")% None 3.83381005225673.ToString("F0")%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. FATE ranks #261 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

All Filings in FATE

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$921,295	767,748	-16.3%	Shares	Defined	2026-05-15
2025-12-31	$898,604	916,946	-1.4%	Shares	Defined	2026-05-27
2025-09-30	$1,171,726	929,944	-61.8%	Shares	Defined	2026-05-27
2025-06-30	$2,725,599	2,433,575	+8.6%	Shares	Defined	2025-08-15
2025-03-31	$1,769,643	2,240,058	-20.6%	Shares	Defined	2025-05-15
2024-12-31	$4,656,600	2,822,183	-7.9%	Shares	Defined	2025-05-15
2024-09-30	$10,721,972	3,063,421	-2.7%	Shares	Defined	2025-05-14
2024-06-30	$10,325,399	3,147,989	+2.7%	Shares	Defined	2025-05-14
2024-03-31	$22,502,886	3,065,789	+132.0%	Shares	Defined	2024-10-17
2023-12-31	$4,941,867	1,321,356	-7.6%	Shares	Defined	2024-08-16
2023-09-30	$3,030,357	1,429,416	+12.0%	Shares	Defined	2023-11-15
2023-06-30	$6,077,717	1,276,832	+1.2%	Shares	Defined	2023-08-14
2023-03-31	$7,194,395	1,262,175	-27.4%	Shares	Defined	2023-05-15
2022-12-31	$17,537,174	1,738,075	+26.9%	Shares	Defined	2023-02-14
2022-09-30	$30,695,444	1,369,721	-15.7%	Shares	Defined	2022-11-14
2022-06-30	$40,249,381	1,624,269	+31.9%	Shares	Defined	2022-10-27
2022-03-31	$47,756,961	1,231,802	-24.5%	Shares	Defined	2022-10-27
2021-12-31	$95,434,253	1,631,076	+53.8%	Shares	Defined	2022-02-14
2021-09-30	$62,840,481	1,060,241	+11.6%	Shares	Defined	2021-11-15
2021-06-30	$82,430,795	949,773	-21.3%	Shares	Defined	2021-08-23
2021-03-31	$99,558,125	1,207,497	+24.2%	Shares	Defined	2021-05-17
2020-12-31	$88,437,969	972,594	+244.5%	Shares	Defined	2021-02-16
2020-09-30	$11,283,848	282,308	+39.0%	Shares	Defined	2020-11-13
2020-06-30	$6,968,257	203,097	-21.7%	Shares	Defined	2020-08-14
2020-03-31	$5,759,740	259,331	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.